Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 14 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

29%

4 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

7 recruiting

Enrollment Performance

Analytics

N/A
3(33.3%)
Phase 4
3(33.3%)
Phase 2
2(22.2%)
Phase 3
1(11.1%)
9Total
N/A(3)
Phase 4(3)
Phase 2(2)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (14)

Showing 14 of 14 trials
NCT06284642Phase 4Recruiting

Early Lumbar Drainage Plus Intrathecal Urokinase in Severe Aneurysmal Subarachnoid Hemorrhage (LD-ITUK)

Role: collaborator

NCT06265051Phase 2Completed

Tirofiban After Successful MT Recanalization in AIS

Role: collaborator

NCT07421895Recruiting

A Prospective Multicenter Observational Real-world Study of Retained Products of Conception

Role: collaborator

NCT07302009Not ApplicableNot Yet Recruiting

Targeted Temperature Management Via Bladder Monitoring in ICH

Role: collaborator

NCT07290699Phase 4Not Yet Recruiting

Intensive Cholesterol-Lowering Within 24 Hours of PCI Perioperative Period

Role: collaborator

NCT07153744Phase 4Not Yet Recruiting

Efficacy and Safety of Shexiang Baoxin Pill(MUSKARDIA) in the Treatment of Acute Myocardial Infarction

Role: collaborator

NCT06943729Recruiting

Clinical Safety and Efficacy of Flow-diverter in the Treatment of Intracranial Aneurysms

Role: collaborator

NCT07093294Recruiting

Value of IUS in Predicting Vedolizumab Efficacy and Assessing Transmural Healing in Early Crohn's Disease: A Multicenter, Prospective Study

Role: collaborator

NCT06924762Phase 2Recruiting

Interleukin-2 for Refractory Chronic Spontaneous Urticaria

Role: collaborator

NCT06742450Not ApplicableRecruiting

Constant Current Versus Constant Voltage Subthalamic Nucleus Deep Brain Stimulation in Patients with Parkinson's Disease

Role: collaborator

NCT05598528Recruiting

Exploring the Mechanism of Primary Resistance to Third-generation EGFR-TKIs as First-line Treatment in EGFR-positive Advanced NSCLC (PRECISE Study)

Role: collaborator

NCT05179733Phase 3Unknown

The Efficacy and Safety of ZR2 Versus R-miniCHOP in the Treatment of Unfit or Frail de Novo Diffuse Large B-cell Lymphoma Patients Aged Older Than or Equal to 70 Years

Role: collaborator

NCT05651893Not ApplicableUnknown

Efficacy of Second Forward-view Examination of Left Colon for Adenoma Detection During Colonoscopy

Role: collaborator

NCT04678934Unknown

Cerebral Lesion and Neurocognitive Status Changes After TAVR

Role: collaborator

All 14 trials loaded